Drug recall · March 20, 2019
Oxybutynin Chloride recall
Why: Failed Dissolution Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
- Lots / codes
Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021
- Quantity
- 14,448 bottles
- Company
- Lannett Company Inc., Seymour, IN
- Distribution
- Nationwide, including Puerto Rico.
- Initiated
- February 21, 2019 · N/A
- Classified
- March 12, 2019
- Reported
- March 20, 2019
- Ended
- November 6, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxybutynin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.